My bookmarksSign up free

2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)

2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Lipid extract from Antarctic Krill Euphausia superba as specified in Annex I, may be placed on the market in the Community as a novel food ingredient for the uses and at the maximum levels as listed in Annex II.

Article 2

The designation ‘lipid extract from the crustacean Antarctic Krill Euphausia superba ’ shall be displayed on the labelling of the product as such or in the list of ingredients of foodstuffs containing it.

Article 3

This Decision is addressed to Neptune Technologies & Bioressources Inc., 225 Promenade du Centropolis, Suite 200, Laval, Quebec H7T 0B3, Canada.

Supplementary provisions

ANNEX ISupplementary provisions

ANNEX I SPECIFICATION OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA Description To produce lipid extract from Antarctic Krill Euphausia superba deep-frozen Antarctic krill is crushed and subjected to an extraction with acetone. Proteins and krill material are removed from the lipid extract by filtration. The acetone and residual water are removed by evaporation. Test Specification Saponification value Not more than 185 mg KOH/g Peroxide value (PV) Not more than 0,2 meq O 2 /kg oil Moisture and volatiles Not more than 0,9 % Phospholipids Not more than 50 % Trans-fatty acids Not more than 1 % EPA (eicosapentaenoic acid) Not less than 15 % DHA (docosahexaenoic acid) Not less than 7 %

ANNEX IISupplementary provisions

ANNEX II USES OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA Use group Maximum content of combined DHA and EPA Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy analogues except drinks 200 mg/100 g or for analogues to cheese products 600 mg/100 g Spreadable fat and dressings 600 mg/100 g Breakfast cereals 500 mg/100 g Food supplements 200 mg per daily dose as recommended by the manufacturer Dietary foods for special medical purposes In accordance with the particular nutritional requirements of the persons for whom the products are intended Foods intended for use in energy restricted diets for weight reduction 200 mg/meal replacement

Other acts of the same type
Council Decision (CFSP) 2025/346 of 18 February 2025 amending Decision (CFSP) 2020/1999 concerning restrictive measures against serious human rights violations and abusesCouncil Implementing Decision (EU) 2025/373 of 18 February 2025 amending Implementing Decision (EU) 2019/310 as regards the authorisation granted to Poland to continue to apply the special measure derogating from Article 226 of Directive 2006/112/EC on the common system of value added taxCouncil Decision (EU) 2025/378 of 18 February 2025 appointing the members and alternate members of the Committee of the Regions for the period from 18 February 2025 to 25 January 2030 and amending Decision (EU) 2025/71Council Decision (EU) 2025/380 of 18 February 2025 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Annex IX (Financial services) to the EEA Agreement (Text with EEA relevance)Council Decision (EU) 2025/381 of 18 February 2025 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Annex IX (Financial services) to the EEA Agreement (Text with EEA relevance)Council Decision (EU) 2025/479 of 18 February 2025 on the conclusion of the Agreement between the European Union and the Republic of Serbia on operational activities carried out by the European Border and Coast Guard Agency in the Republic of SerbiaCouncil Decision (EU) 2025/490 of 18 February 2025 on the conclusion, on behalf of the European Union, of an Agreement on the participation of the Republic of Croatia in the European Economic Area, and of three related agreementsCouncil Decision (Euratom) 2025/492 of 18 February 2025 approving a Commission regulation on the application of Euratom safeguardsCouncil Decision (EU) 2025/1531 of 18 February 2025 on the signing, on behalf of the Union, and provisional application of the Agreement between the European Union, of the one part, and the Republic of Korea, of the other part, on the participation of the Republic of Korea in Union programmesCommission Implementing Decision (EU) 2025/308 of 14 February 2025 establishing a uniform format for the report on the reintroduction or prolongation of border control at internal borders in accordance with Article 33 of Regulation (EU) 2016/399 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2025/315 of 14 February 2025 establishing a template for the notification of the temporary reintroduction or prolongation of border control at internal bordersCouncil Decision (CFSP) 2025/334 of 14 February 2025 amending Decision (CFSP) 2024/583 on a European Union maritime security operation to safeguard freedom of navigation in relation to the Red Sea crisis (EUNAVFOR ASPIDES)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next